Trial intelligence / Profile preview

Peri-femoral artery local anesthetic injection added to femoral and sciatic nerve block for prevention of thigh tourniquet-induced hypertension

TCTR20210524009Phase 2Completed

Sponsor
N/A
Start
Sep 2021
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 2 trial of ropivacaine in hypertension (HTN), sponsored by N/A. Started Sep 2021; status: completed.

02

Drugs

ropivacaine
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on TCTR20210524009.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20210524009.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call